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Abstract
Background The SEL1L gene is located on human chromosome 14q24.3-31
close to D14S67 which has been previously proposed to be a type 1 diabetes
mellitus locus (IDDM11). Sel-1 is a negative regulator of the Notch signalling
pathway and SEL1L is selectively expressed in adult pancreas and islets of
Langerhans. This suggests that SEL1L may be a candidate gene for IDDM11.
Methods We have analysed two newly identified CA-repeat polymorphisms
within the genomic sequence of the SEL1L locus for association with type 1
diabetes mellitus (T1DM) in 152 Danish T1DM-affected sib-pair families and
in 240 Sardinian families (229 simplex and 11 sib-pair families).
Results No evidence for association of the two SEL1L markers with T1DM
was observed in either the Danish or the Sardinian families. We have also
used allelic sharing methods to analyse linkage with T1DM in the IDDM11
region using the same markers and the Danish collection of affected sib-pair
families. No evidence of linkage was observed (Zmax=0.86).
Conclusion Although several lines of evidence suggest that SEL1L might be
a candidate for IDDM11-conferred susceptibility to T1DM the present study
does not support this hypothesis. Copyright # 2001 John Wiley & Sons, Ltd.
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Introduction
Type 1 diabetes mellitus (T1DM) results from an immune-mediated
destruction of the insulin-producing b cells of the pancreas. Predisposition
to the disease is polygenic. It is now clear that while HLA region genes
contribute the major predisposition to the disease, there are numerous other
genes with smaller effects on susceptibility. With the exception of IDDM2,
these ‘minor’ predisposing genes have only been localized, not yet identified.
In the present study, we have evaluated SEL1L as a candidate gene for
IDDM11-conferred susceptibility. SEL1L, which was recently cloned [1,2], is
the human homologue of the Caenorhabditis elegans gene sel-1. Sel-1 is an
important negative regulator of the Notch signalling pathway [3] that acts as
a key regulator of the cellular differentiation processes. Notch signalling was
recently shown to be important for proper development of pancreatic
endocrine cells [4–6]. SEL1L is ubiquitously expressed in human fetal tissues,
but it exhibits high mRNA levels only in adult pancreas [7] and in islets of
Langerhans [8]. Furthermore, a series of recent studies revealed that apart
from the well-documented involvement of Notch in differentiation [9], both
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proliferation [10] and apoptotic [11] events can be
affected by Notch signalling. Preliminary studies on
pancreatic sections indicate accumulation of SEL1L
protein in the acini and in a subpopulation of cells in
the islet of Langerhans (I. Biunno, unpublished data).
SEL1L is located on human chromosome 14q24.3-31
about 4.7 Mb proximal to D14S67 [2], a marker for the
putative type 1 diabetes mellitus susceptibility locus,
IDDM11 (OMIM 601208) [12]. The SEL1L gene comprises
21 exons and spans 70 kb of genomic DNA [2]. Two new
and significantly polymorphic (CA)n repeats positioned in
intron 2 (GenBank Accession No. G44759) and intron 20
(GenBank Accession No. G44758) of the SEL1L gene,
respectively, were recently reported [2].
We have analysed 152 Danish Caucasoid T1DM multi-
plex families and 240 Sardinian T1DM simplex families
for these two microsatellite markers as possible candidate
markers for IDDM11 in addition to D14S67, the original
marker of IDDM11 [12].
Subjects and methods
Subjects
The 152 Danish families comprised 311 affected and 137
unaffected offspring. In 108 families both parents and in
44 families one parent only were available for genotyp-
ing. All diabetic offspring were diagnosed according to
WHO criteria before the age of 30 years (mean age at
onset tSD: 13.6t9.3 years) [13,14]. HLA conditioning
was performed as follows: HLA DR3/4 heterozygous
patients were assigned highest risk, whereas non-HLA
DR3/4 were defined as lower risk. The 240 Sardinian
families comprised 253 affected and 194 unaffected
offspring. The appropriate ethics committees approved
the study.
Genotyping
Genotyping for D14S67, G44759 and G44758 was
performed using the following primers: F: 5k-ttcac
tacgcctctacaattctatg, R: 5k-TAGTCAGGGTTTGCCAGAGA,
F: 5k-TGGGCTTGGTTAGTACTTGG, R: 5k-AAAATTACT
GACCTACAAGAGGG, F: 5k-CGTATTGGATTACTGGTG
GAAAG, and R: 5k-GGCAAGGAACTGGGAAAGTTAC,
respectively. All forward primers were 5k-fluorescense
labelled. The PCR reactions were performed under
standard conditions in 20 ml final volume using
0.5–1.0 mM of each primer and 0.5 U Taq polymerase
(Gibco BRL, Paisley, UK) in a thermal cycler 9700
(Applied Biosystems, Foster City, CA, USA). After 95uC
for 5 min and 33 cycles at 95uC for 30 s, 62uC for
1 min and 72uC for 1 min followed by 72uC for
10 min, PCR products were analysed on a ABI PRISM
310 Genetic Analyzer (Applied Biosystems) using
standard software.
Statistical analysis
Transmission of microsatellite marker alleles was assessed
from heterozygous parents to both affected and un-
affected offspring using the transmission disequilibrium
test (TDT) [15,16]. The TDT statistics (Tsp) described by
Martins et al. [17] was used, which combines sib-pair and
simplex families in a single test. In particular, the Tsp
version of the TDT takes into account the presence of
linkage in a proportion of the sib-pairs and allows the data
from the second sib to be included, thereby giving a
completely valid test of association. Linkage was analysed
using the Genehunter software package version 1.2 [18].
Table 1. Transmission of the four most common alleles of G44759 (intron 2) and G44758 (intron 20) of the SEL1L locus to
affected and unaffected offspring in Danish and Sardinian type 1 diabetes families
Affected offspring Unaffected offspring
Allele T NT %T p* Allele T NT %T x2 p*
DK
G44759 2 79 81 49 0.911 2 29 25 54 0.296 0.586
5 61 60 50 0.931 5 23 25 48 0.083 0.773
9 40 42 49 0.869 9 19 21 48 0.100 0.752
8 14 16 47 0.756 8 4 3 57 0.143 0.705
SAR
G44759 2 78 56 58 0.057 2 61 60 50 0.008 0.928
5 52 68 43 0.144 5 52 57 48 0.229 0.632
9 26 32 45 0.431 9 29 27 52 0.071 0.789
8 14 15 48 0.853 8 15 13 54 0.143 0.705
DK
G44758 2 58 50 54 0.492 2 22 21 51 0.023 0.880
7 53 50 52 0.801 7 19 17 53 0.111 0.739
6 44 47 48 0.779 6 22 14 61 1.778 0.182
8 9 20 31 0.044 8 1 9 10 6.400 0.011
SAR
G44758 2 63 67 49 0.726 2 55 52 51 0.084 0.772
7 53 54 50 0.923 7 53 42 56 1.274 0.259
6 55 48 53 0.490 6 46 48 49 0.043 0.837
8 17 20 46 0.622 8 13 21 38 1.882 0.170
DK, Danish data set; SAR, Sardinian data set; T, transmitted (n); NT, not transmitted; p*, uncorrected p values.
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Results
No evidence of association to T1DM of the SEL1L G44758
and G44759 microsatellites was found by use of the TDT
in either the Danish families or the Sardinian families
(Table 1).
In both the Danish and Sardinian data sets the same
four alleles of each marker were the most common
(Table 1). Alleles 2, 5, 9 and 8 of G44759 comprised
90.0% of all transmissions in the Danish families and
95.0% in the Sardinian families. Alleles 2, 7, 6 and 8 of
G44758 accounted for 77.3% of all transmissions in the
Danish and 95.4% in the Sardinian families. Since no
significant differences were seen between the Danish and
Sardinian data between affected and non-affected indi-
viduals the two data sets were combined for analysis of
association. No significant differences in transmission
patterns were observed in the combined data set.
Conditioning for HLA risk did not reveal association in
either the Danish or the Sardinian data set or in the data
combined (data not shown). Also, no significant differ-
ences were observed for comparing transmission patterns
of the two markers to affected versus unaffected offspring
in either the Danish or the Sardinian data sets [p=0.2
(DK G44759), p=0.9 (SAR G44759), p=0.2 (DK
G44758) and p=0.5 (SAR G44758)].
In an attempt to replicate the original observation by
Field et al. [12], D14S67 was tested in the Danish affected
sib-pairs. However, no evidence for linkage of T1DM to
D14S67 (single point NPL=1.22; p=0.11) was found.
Also, TDT provided negative results at D14S67 ( p=0.25)
(data not shown). Multipoint analysis including G44759,
G44758 and D14S67 resulted in a Zmax of 0.86 ( p=0.2).
Thus, also testing the IDDM11 region [12] with allelic
sharing methods revealed negative results and a gene
effect equivalent to ls=1.5 could be excluded at Lod –2.
Discussion
We have identified SEL1L as a positional and possible
functional candidate gene for IDDM11-conferred suscept-
ibility to T1DM [2]. In the present study no evidence
was found for association of the two tested SEL1L
microsatellite markers to T1DM in either the Danish or
the Sardinian the data set or in the combined data set. In
the Danish data set no evidence for linkage was observed
for D14S67 in the affected sib-pair analysis nor for
association using the TDT. HLA conditioning did not
reveal evidence for association of any of the SEL1L
markers. Given the well-known results on the insulin
VNTR [19] in T1DM and of calpain-10 in type 2 diabetes
[20], a true association could be present even when
linkage analysis failed to show evidence of linkage, and
we cannot rule out that specific variation(s) in the SEL1L
gene sequence can be associated with T1DM. Interest-
ingly, several correlations between mutations in Notch-
like genes and human diseases have been reported. These
include cancer, stroke, late-onset neurological disease
(CADASIL) and Alagille syndrome [21,22], highlighting
the broad spectrum of Notch activity in humans. Detailed
mutation scanning of the SEL1L sequence (Z. Larsen et al.,
unpublished observations) revealed a number of incon-
sistencies with earlier reported sequences [1,2], and
could not confirm the presence of previously reported
polymorphisms of the cDNA sequence. However, altera-
tion(s) in genes such as SEL1L could cause disruption of
the normal pancreatic organogenesis developmental
program(s) that, in turn, may cause defects in the
genes that regulate pancreatic islet development and
insulin biosynthesis. In addition, studies have indicated
that Notch plays a fundamental role in the lineage
decision of T-cell development [23]. It may be that Notch
confers selective survival and/or cell proliferation on cells
that have already made a lineage decision. Hence, data
exist to imply an interaction (direct or indirect) between
SEL1L and Notch proteins that presently are unknown. In
C. elegans, mutations in sel-1 leads to a reduction in lin-12
activity [24]; in rodent and man this association has not
as yet been established.
In conclusion, although several lines of evidence
suggest that SEL1L might be a candidate for IDDM11-
conferred susceptibility to T1DM, the present study does
not support this. However, it cannot be excluded that
specific mutations in the gene could be of etiological
relevance for T1DM development.
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